Merck ( Merck )


Merck's picture

Merck Press Release and News

Merck press release, blog etc

04/17/2018 - 06:12 Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine
04/17/2018 - 05:51 Merck Advances Clean Energy Goals with Invenergy
04/14/2018 - 23:56 Updated Overall Survival Data for LYNPARZA (olaparib) in gBRCA-mutated HER2-Negative Metastatic Breast Cancer Presented at AACR
04/03/2018 - 04:25 The European Medicines Agency Accepts Regulatory Submission for LYNPARZA (olaparib) in BRCA-Mutated HER2-Negative Metastatic Breast Cancer
04/02/2018 - 10:51 Merck Receives 2018 ENERGY STAR Sustained Excellence Award
04/02/2018 - 06:05 Merck to Hold First-Quarter 2018 Sales and Earnings Conference Call on May 1
03/20/2018 - 22:45 MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO Plus (fluralaner plus moxidectin) Spot-on Solution for Cats
03/20/2018 - 14:14 Merck Announces Appointment of Jennifer Zachary as General Counsel
03/01/2018 - 09:22 Merck to Present New Data from Studies of Investigational HIV Therapies Doravirine and MK-8591 at CROI 2018
02/23/2018 - 07:04 LYNPARZA (olaparib) Receives Positive EU CHMP Opinion in Platinum-Sensitive Relapsed Ovarian Cancer
02/22/2018 - 13:28 Ferring Pharmaceuticals and Merck Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Hemorrhage
02/21/2018 - 04:30 Merck and Viralytics Announce Acquisition Agreement, Expanding Mercks Leading Immuno-Oncology Pipeline
02/15/2018 - 07:45 Selumetinib Granted Orphan Drug Designation by the U.S. FDA for Neurofibromatosis Type 1
02/13/2018 - 14:55 Merck Announces Discontinuation of APECS Study Evaluating Verubecestat (MK-8931) for the Treatment of People with Prodromal Alzheimers Disease
02/06/2018 - 15:40 First-of-its-Kind Study Reveals Concern about the Future of the Veterinary Profession
01/31/2018 - 04:46 Pro Football Hall of Famer and Cancer Survivor Jim Kelly Joins Merck to Challenge America to Raise Funds for the Cancer Community
01/24/2018 - 17:07 Inge Thulin Elected to Merck Board of Directors
01/19/2018 - 16:07 LYNPARZA (olaparib) Receives Approval in Japan for the Treatment of Advanced Ovarian Cancer